AUR vs. G, HGTY, DNA, KIND, EPAM, VERX, CRUS, EEFT, CLVT, and BILI
Should you be buying Aurora Innovation stock or one of its competitors? The main competitors of Aurora Innovation include Genpact (G), Hagerty (HGTY), Ginkgo Bioworks (DNA), Nextdoor (KIND), EPAM Systems (EPAM), Vertex (VERX), Cirrus Logic (CRUS), Euronet Worldwide (EEFT), Clarivate (CLVT), and Bilibili (BILI).
Genpact (NYSE:G) and Aurora Innovation (NASDAQ:AUR) are both mid-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.
Genpact has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, Aurora Innovation has a beta of 2.91, meaning that its share price is 191% more volatile than the S&P 500.
In the previous week, Genpact had 6 more articles in the media than Aurora Innovation. MarketBeat recorded 13 mentions for Genpact and 7 mentions for Aurora Innovation. Genpact's average media sentiment score of 0.95 beat Aurora Innovation's score of 0.27 indicating that Aurora Innovation is being referred to more favorably in the news media.
Genpact has higher revenue and earnings than Aurora Innovation. Aurora Innovation is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.
Genpact has a net margin of 14.10% compared to Genpact's net margin of 0.00%. Aurora Innovation's return on equity of 23.19% beat Genpact's return on equity.
Genpact presently has a consensus price target of $40.11, suggesting a potential upside of 30.95%. Aurora Innovation has a consensus price target of $3.75, suggesting a potential upside of 21.75%. Given Aurora Innovation's higher possible upside, research analysts clearly believe Genpact is more favorable than Aurora Innovation.
96.0% of Genpact shares are held by institutional investors. Comparatively, 44.7% of Aurora Innovation shares are held by institutional investors. 2.8% of Genpact shares are held by insiders. Comparatively, 13.8% of Aurora Innovation shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Genpact received 482 more outperform votes than Aurora Innovation when rated by MarketBeat users. Likewise, 68.54% of users gave Genpact an outperform vote while only 33.33% of users gave Aurora Innovation an outperform vote.
Summary
Genpact beats Aurora Innovation on 12 of the 16 factors compared between the two stocks.
Get Aurora Innovation News Delivered to You Automatically
Sign up to receive the latest news and ratings for AUR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Aurora Innovation Competitors List
Related Companies and Tools